ShareThis Page
$322 million expansion in store for Eli Lilly & Co. |

$322 million expansion in store for Eli Lilly & Co.

The Associated Press
| Friday, August 22, 2003 12:00 a.m

INDIANAPOLIS — Eli Lilly & Co. said it will spend $322 million to expand its drug manufacturing complex near downtown Indianapolis, adding to its manufacturing, office and laboratory space.

Lilly needs an additional 456,000 square feet of space “to prepare for what is a growing portfolio of products we’ll introduce over the next couple of years,” company spokesman Edward Sagebiel told the city’s development commission Wednesday. The project, to start this year, could take up to three years to complete.

The commission granted the drug maker preliminary approval for a $314 million property tax abatement over 10 years. Under a 1999 deal with the city and state, Lilly committed to hire 7,500 more employees locally by 2010. So far, it has hired more than 4,000, Sagebiel said.

An insulin finishing facility will be renovated, and two new administrative buildings will replace aging modular structures that will be demolished to make way for future construction. Another new building will be for the manufacture of a longer-lasting form of Lilly’s top-selling drug, the anti-psychotic Zyprexa.

Lilly executive William E. Smith III said the construction was not directly related to Food and Drug Administration inspections in 2001 that found eight Lilly operations failed to meet quality-control standards.

“This is not a case where the FDA said, ‘You ought to have these buildings,’ ” Smith said.

The plan includes four new projects on the heels of $1 billion in construction that was completed this year.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.